1. TyG-GGT is a Reliable Non-Invasive Predictor of Advanced Liver Fibrosis in Overweight or Obese Individuals.
- Author
-
Jin, Lei, Gu, Jing, Zhang, Zhe, Du, Cheng-Fei, Xu, Fei-Qi, Huang, Xiao-Kun, Gao, Zhen-Yu, Li, Ying, Yu, Li-Li, Zhang, Xin, Ru, Guo-Qing, Liu, Jun-Wei, Liang, Lei, Sun, Xiao-Dong, and Xiao, Zun-Qiang
- Subjects
HEPATIC fibrosis ,LIVER histology ,NON-alcoholic fatty liver disease ,BODY mass index ,BARIATRIC surgery ,FATTY liver ,CIRRHOSIS of the liver ,OBESITY - Abstract
Background: Liver fibrosis is a predisposing factor for liver cancer. This study will investigate the predictive role of the Triglyceride-glucose and Gamma-glutamyl transferase index (TyG-GGT) as a non-invasive indicator of advanced liver fibrosis in individuals with obesity or overweight. Method: We enrolled patients who underwent metabolic and bariatric surgery as well as intraoperative liver biopsies at Zhejiang provincial people's hospital from August 2020 to March 2023. Clinical characteristics, comorbidities, laboratory data, and pathological variables of patients were collected and analysed. Then, we conducted logistics regression model to compare the performance of the TyG-GGT index with other 4 non-invasive models. Results: A total of 65 patients were included in this study. 43(66.2%) of them were female, with the mean body mass index (BMI) of 39.0 ± 7.3 kg/m2. Meanwhile, 24(36.9%) patients were diagnosed with diabetes. Advanced liver fibrosis were observed in 16.9% of patients, while liver cirrhosis was found in 4.6% of patients. The multivariable logistics regression showed that TyG-GGT was an independent risk factor of advanced liver fibrosis (OR = 6.989, P = 0.049). Additionally, compared to another 4 non-invasive liver fibrosis models (NFS = 0.66, FIB4 = 0.65, METS-IR = 0.68, APRI = 0.65), TyG-GGT exhibits the highest AUC value of 0.75. Conclusions: More than one-third of patients undergoing metabolic and bariatric surgery are afflicted with nonalcoholic steatohepatitis (NASH), and a significant proportion exhibit advanced fibrosis. TyG-GGT was a potentially reliable predictor for screening individuals with overweight or obesity at high risk of advanced liver fibrosis, thus providing clinical guidance for early intervention in this targeted group. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF